The government has begun to operate an emergency operation center (EOC) to support the transfer of emergency patients among hospitals in response to trainee physicians’ massive walkouts.To deal with doctors’ collective action, the Ministry of Health and Welfare said it began operating the EOC, a tem
The Korean medical community is facing an unprecedented crisis as tensions escalate between the government and healthcare professionals over the proposed increase in medical school admissions by 2,000 in 2025.The dispute has broadened from trainee doctors to encompass the entire medical sector, with
GSK Korea's inhalation-type triple combination asthma medicines Trelegy 100 Ellipta (fluticasone furoate/umeclidinium/vilanterol) and Trelegy200 Ellipta will get health insurance benefits starting this month.According to a notice by the Ministry of Health and Welfare and the Health Insurance Review
The government's survey, demanding adjustments to the medical school enrollment quotas of 40 universities with medical programs, is scheduled to conclude at midnight on Thursday.Against this backdrop, university presidents and medical professors at some universities clash with each other over this c
i-SENS, a Kosdaq-listed biotech company, said it received product approval for CareSens Air, its continuous glucose monitoring (CGM) device, from the European Conformité Européenne (CE) Medical Device Regulation (MDR) last Thursday.The CareSens Air CGM system offers a non-invasive solution for diabe
Coreline Soft's AVIEW Aorta has been recognized as an innovative medical device with insurance benefits, broadening its application in emergency medicine and establishing itself as a new source of revenue.On Monday, the medical AI company announced that AVIEW Aorta, a class 3 cardiovascular image de
Samjin Pharmaceutical announced a strategic investment of 1 billion won ($751,371) in Neurophet, a company specializing in AI solutions for brain disorder imaging, to fight dementia and stroke.Under the accord, the two companies seek to leverage Samjin’s extensive research resources, infrastructure,
The Korea Drug Research Association held the 25th Korea New Drug Development Award Ceremony in Seoul last Thursday.At the ceremony, Yuhan Corp., which developed the non-small cell lung cancer (NSCLC) treatment Leclaza, and GC Biopharma’s immune disease treatment Alyglo co-won the grand prize in the
The Middle East is gaining attention as an emerging market for Korean medical equipment manufacturers.Many medical device makers, including Waycen and Osstem Implant, have recently participated in Arab Health 2024, Medlab Middle East 2024, and AEEDC Dubai to promote new technologies and sign export
The World Medical Association (WMA) has issued a statement calling on the Korean government to discontinue coercive measures against the medical community.However, the Ministry of Health and Welfare countered that the WMA represents the one-sided views of the Korean Medical Association (KMA)."The Wo
Hugel said it received approval from the U.S. FDA for its botulinum toxin product, Letybo, in 50-unit and 100-unit dosages.This FDA approval marks a significant development for Hugel, following its third attempt to gain approval for Letybo.The company's journey to this point involved addressing feed
Celltrion said it reported consolidated sales of 2.1 trillion won ($1.5 billion) and operating income of 651 billion won in 2023, down 4.71 percent and up 0.66 percent, respectively, from the previous year.The company also posted a net profit of 539.2 billion won, down 0.53 percent, and an operating
Despite the government's ultimatum for disciplinary actions ending on Thursday, thousands of Korean medical residents have yet to return to work. As of Tuesday, a total of 9,267 residents from 100 training hospitals were ordered to return, with 5,976 confirmed to have not complied with the order.Vic
Pharmbio Korea will exclusively sell Clipper (beclomethasone dipropionate), an original ulcerative colitis treatment from Italian pharmaceutical company Chiesi, in Korea.Clipper is a steroidal ulcerative colitis treatment, a long-acting extended-release tablet that provides the anti-inflammatory ben
No fewer than 3,093 students applied for five additional medical school recruitments for the class of 2024, reaffirming a “medical school craze” that went way beyond simple concentration.Jongro Academy, a prominent extracurricular educational institute, has disclosed application details of 22 medica
Biologic agent Dupixent (dupilumab) has emerged as a new treatment option for moderate-to-severe nodular pruritic rash (prurigo nodularis), for which existing treatments, such as topical steroids and systemic immunosuppressants, have shown little treatment effects.On Wednesday, Sanofi Korea held a n
CHA Biotech said it had achieved its highest-ever annual revenue, posting a consolidated revenue of 954 billion won ($798 million) for the year 2023, up 13 percent from the previous year, thanks to strong business performance overseas.Despite the global economic slowdown, CHA Biotech attributed its
NGeneBio, a precision diagnostics platform company, has received approval from the Thai Food and Drug Administration (TFDA) to market HLAaccuTest™ All, an in vitro diagnostic medical device based on next-generation sequencing (NGS) technology.It is the fourth NGS-based product approved for registrat
Kolon Life Science said it has decided to appeal to the Supreme Court against the revocation of the manufacturing and sales license for its knee osteoarthritis cell and gene therapy, Invossa-K Inj.This move comes after the company faced defeats in both the district and appellate courts.Most recently
Biotech companies developing new drugs are plagued by rumors that adversely affect investor sentiment.Faced with a series of speculations about the equity sale by the largest shareholders and plans for a capital increase, SCM Lifescience, ABL Bio, NKMAX, and Genome & Company have responded with offi